Fetal exposure to bisphenol A as a risk factor for the development of childhood asthma: an animal model study

BackgroundThe prevalence of asthma in industrialized countries has been increasing dramatically and asthma is now the most common chronic disease of children in the United States. The rapidity of the increase strongly suggests that changes in environmental exposures are the likely cause of this epidemic. Further, the early onset of allergic manifestations suggests that these exposures may act on the prenatal development of the immune system. We have focused on the potential effects of bisphenol A (BPA), a chemical pollutant with one of the largest productions, on the development of childhood asthma. We have reported that perinatal BPA exposure promotes the development of allergic asthma in a mouse model. The current study was designed to identify a critical period of BPA exposure and to begin elucidating the mechanisms for this susceptibility.MethodsFemale BALB/c mice received 10 micro g/ml BPA in their drinking water from one week before pregnancy until the end of the study. Some of the pups were transferred in the first 48 h of life from their BPA-loaded mother to an unexposed mother, or vice versa. Half of the pups were sensitized with a low dose of the experimental allergen ovalbumin (OVA), the rest received PBS as an unsensitized controls. On day 22, the pups were challenged by inhalations of ovalbumin or PBS followed by quantification of eosinophils in and hyperreactivity of their airways, major indicators of experimental asthma in this classical mouse model. Hepatic expression of two isoforms of UDP-glucuronosyltransferase (Ugt) was quantified by quantitative RT-PCR at various ages.ResultsPups exposed to BPA in utero and through breast milk, or in utero only, displayed an asthma phenotype in response to their "suboptimal" allergic sensitization, whereas, pups only exposed to BPA postnatally from breast milk, did not. The expression of Ugt2b1, an isoform related to BPA clearance in rats, was not detectable in mouse fetuses and newborn pups, but increased by day 5 and approached adult levels by day 25.ConclusionsPrenatal exposures that produce environmentally relevant burdens of BPA, followed by postnatal allergic sensitization and challenges, promote the development of experimental allergic asthma. Delayed expression of BPA-metabolizing enzymes may explain, at least in part, the enhanced fetal susceptibility to this common environmental contaminant.

[1]  R. Alyea,et al.  Differential Regulation of Dopamine Transporter Function and Location by Low Concentrations of Environmental Estrogens and 17β-Estradiol , 2009, Environmental health perspectives.

[2]  Koji Arizono,et al.  Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.

[3]  I. Tsuge,et al.  Up‐regulated cytokine‐inducible SH2‐containing protein expression in allergen‐stimulated T cells from hen's egg‐allergic patients , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  C. Falany,et al.  Developmental Expression of Aryl, Estrogen, and Hydroxysteroid Sulfotransferases in Pre- and Postnatal Human Liver , 2006, Journal of Pharmacology and Experimental Therapeutics.

[5]  C. Guillemette,et al.  Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. , 2005, Pharmacogenetics and genomics.

[6]  A. Porath,et al.  Sub-clinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic post-menopausal women. , 1995, Maturitas.

[7]  S. Narimatsu,et al.  Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation. , 2008, Chemosphere.

[8]  C. Vionnet [Environmental health]. , 1983, Krankenpflege. Soins infirmiers.

[9]  D. Lubahn,et al.  Estrogen Receptor α (ERα) Deficiency in Macrophages Results in Increased Stimulation of CD4+ T Cells while 17β-Estradiol Acts through ERα to Increase IL-4 and GATA-3 Expression in CD4+ T Cells Independent of Antigen Presentation1 , 2005, The Journal of Immunology.

[10]  F. Speizer,et al.  Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. , 2004, Archives of internal medicine.

[11]  G. Lucier,et al.  Glucuronidation and deglucuronidation reactions in hepatic and extrahepatic tissues during perinatal development. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[12]  S. Kadota,et al.  Sulfation of environmental estrogens by cytosolic human sulfotransferases. , 2002, Drug metabolism and pharmacokinetics.

[13]  P. Mackenzie,et al.  Steroid UDP glucuronosyltransferases , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  Y. Shiotsu,et al.  Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. , 2002, The Journal of clinical endocrinology and metabolism.

[15]  H. Kabuto,et al.  Exposure to bisphenol A during embryonic/fetal life and infancy increases oxidative injury and causes underdevelopment of the brain and testis in mice. , 2004, Life sciences.

[16]  H. Yokota,et al.  Developmental increases in rat hepatic microsomal UDP-glucuronosyltransferase activities toward xenoestrogens and decreases during pregnancy. , 2002, Environmental health perspectives.

[17]  A. Buist,et al.  20-year trends in the prevalence of asthma and chronic airflow obstruction in an HMO. , 1998, American journal of respiratory and critical care medicine.

[18]  D. McNeel,et al.  CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells , 2011, Cancer Immunology, Immunotherapy.

[19]  S. Ikushiro,et al.  Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. , 1999, The Biochemical journal.

[20]  I. Chahoud,et al.  Parent bisphenol A accumulation in the human maternal-fetal-placental unit. , 2002, Environmental health perspectives.

[21]  J. Steven Leeder,et al.  Glucuronidation in Humans , 1999, Clinical pharmacokinetics.

[22]  T. Midoro-Horiuti,et al.  Maternal Bisphenol A Exposure Promotes the Development of Experimental Asthma in Mouse Pups , 2009, Environmental health perspectives.

[23]  T. Midoro-Horiuti,et al.  Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. , 2007, Molecular immunology.

[24]  H. Kagechika,et al.  The endocrine disruptors nonylphenol and octylphenol exert direct effects on T cells to suppress Th1 development and enhance Th2 development. , 2004, Immunology letters.

[25]  D. Martino,et al.  Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease , 2010, Allergy.

[26]  Y. Shimohigashi,et al.  Direct Evidence Revealing Structural Elements Essential for the High Binding Ability of Bisphenol A to Human Estrogen-Related Receptor-γ , 2007, Environmental health perspectives.

[27]  Catherine M. Sawai,et al.  Effect of bisphenol A on murine immune function: modulation of interferon-gamma, IgG2a, and disease symptoms in NZB X NZW F1 mice. , 2003, Environmental health perspectives.

[28]  D. Lubahn,et al.  Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. , 2005, Journal of immunology.

[29]  Huimin Yan,et al.  Exposure to Bisphenol A Prenatally or in Adulthood Promotes TH2 Cytokine Production Associated with Reduction of CD4+CD25+ Regulatory T Cells , 2008, Environmental health perspectives.

[30]  Yuhong Xiang,et al.  Role of Breast Milk in a Mouse Model of Maternal Transmission of Asthma Susceptibility1 , 2006, The Journal of Immunology.

[31]  J Pinkerton,et al.  Maternal bisphenol-A levels at delivery: a looming problem? , 2008, Journal of Perinatology.

[32]  H. Schild,et al.  Genetic Variation Determines Mast Cell Functions in Experimental Asthma , 2011, The Journal of Immunology.

[33]  A. Flanagin,et al.  Enhancing the Quality and Visibility of African Medical and Health Journals , 2008, Environmental health perspectives.

[34]  M. Manns,et al.  Developmental aspects of human hepatic drug glucuronidation in young children and adults , 2002, Gut.

[35]  J. Ring,et al.  Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE‐independent mast cell degranulation elicited by neuromuscular blocking agents , 2010, Experimental dermatology.

[36]  M. Kowalski,et al.  Endocrine disrupters – potential modulators of the immune system and allergic response , 2006, Allergy.

[37]  L. Kobzik,et al.  Allergen-Independent Maternal Transmission of Asthma Susceptibility 1 , 2003, The Journal of Immunology.